IL92238A - ADMN blocking product containing tetrahydrocannabinol history, several new tetrahydrocannabinol histories and process for their preparation - Google Patents

ADMN blocking product containing tetrahydrocannabinol history, several new tetrahydrocannabinol histories and process for their preparation

Info

Publication number
IL92238A
IL92238A IL9223889A IL9223889A IL92238A IL 92238 A IL92238 A IL 92238A IL 9223889 A IL9223889 A IL 9223889A IL 9223889 A IL9223889 A IL 9223889A IL 92238 A IL92238 A IL 92238A
Authority
IL
Israel
Prior art keywords
composition according
designates
pharmaceutical composition
nmda
compound
Prior art date
Application number
IL9223889A
Other languages
English (en)
Hebrew (he)
Other versions
IL92238A0 (de
Inventor
Sokolov Modechai
Mechoulam Raphael
Original Assignee
Yissum Res Dev Co
Univ Ramot
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IL9223889A priority Critical patent/IL92238A/en
Application filed by Yissum Res Dev Co, Univ Ramot filed Critical Yissum Res Dev Co
Publication of IL92238A0 publication Critical patent/IL92238A0/xx
Priority to EP90312147A priority patent/EP0427518B1/de
Priority to DK90312147.3T priority patent/DK0427518T3/da
Priority to AU65834/90A priority patent/AU631262B2/en
Priority to AT90312147T priority patent/ATE119898T1/de
Priority to DE69017839T priority patent/DE69017839T2/de
Priority to ES90312147T priority patent/ES2071786T3/es
Priority to ZA908914A priority patent/ZA908914B/xx
Priority to KR1019900018114A priority patent/KR950005914B1/ko
Priority to CA002029419A priority patent/CA2029419C/en
Priority to JP2302296A priority patent/JPH0768235B2/ja
Priority to US07/865,088 priority patent/US5284867A/en
Priority to US08/192,886 priority patent/US5521215A/en
Publication of IL92238A publication Critical patent/IL92238A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL9223889A 1989-11-07 1989-11-07 ADMN blocking product containing tetrahydrocannabinol history, several new tetrahydrocannabinol histories and process for their preparation IL92238A (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
IL9223889A IL92238A (en) 1989-11-07 1989-11-07 ADMN blocking product containing tetrahydrocannabinol history, several new tetrahydrocannabinol histories and process for their preparation
EP90312147A EP0427518B1 (de) 1989-11-07 1990-11-06 NMDA-blockierende Verbindungen, pharmazeutische Präparate, deren Herstellung und Verwendung
DK90312147.3T DK0427518T3 (da) 1989-11-07 1990-11-06 NMDA-blokerende forbindelser, farmaceutiske præparater, deres fremstilling og anvendelse
AU65834/90A AU631262B2 (en) 1989-11-07 1990-11-06 Nmda-blocking pharmaceutical compositions
AT90312147T ATE119898T1 (de) 1989-11-07 1990-11-06 Nmda-blockierende verbindungen, pharmazeutische präparate, deren herstellung und verwendung.
DE69017839T DE69017839T2 (de) 1989-11-07 1990-11-06 NMDA-blockierende Verbindungen, pharmazeutische Präparate, deren Herstellung und Verwendung.
ES90312147T ES2071786T3 (es) 1989-11-07 1990-11-06 Compuestos bloqueadores de nmda, composiciones farmaceuticas, su preparacion y su uso.
ZA908914A ZA908914B (en) 1989-11-07 1990-11-07 Nmda-blocking pharmaceutical composition
JP2302296A JPH0768235B2 (ja) 1989-11-07 1990-11-07 Ｎｍｄａ遮断薬剤組成物
KR1019900018114A KR950005914B1 (ko) 1989-11-07 1990-11-07 Nmda-차단 제약조성물
CA002029419A CA2029419C (en) 1989-11-07 1990-11-07 Nmda-blocking pharmaceutical compositions
US07/865,088 US5284867A (en) 1989-11-07 1992-04-08 NMDA-blocking pharmaceutical compositions
US08/192,886 US5521215A (en) 1989-11-07 1994-02-07 NMDA-blocking pharmaceuticals

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL9223889A IL92238A (en) 1989-11-07 1989-11-07 ADMN blocking product containing tetrahydrocannabinol history, several new tetrahydrocannabinol histories and process for their preparation

Publications (2)

Publication Number Publication Date
IL92238A0 IL92238A0 (de) 1990-07-26
IL92238A true IL92238A (en) 1995-07-31

Family

ID=11060554

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9223889A IL92238A (en) 1989-11-07 1989-11-07 ADMN blocking product containing tetrahydrocannabinol history, several new tetrahydrocannabinol histories and process for their preparation

Country Status (11)

Country Link
EP (1) EP0427518B1 (de)
JP (1) JPH0768235B2 (de)
KR (1) KR950005914B1 (de)
AT (1) ATE119898T1 (de)
AU (1) AU631262B2 (de)
CA (1) CA2029419C (de)
DE (1) DE69017839T2 (de)
DK (1) DK0427518T3 (de)
ES (1) ES2071786T3 (de)
IL (1) IL92238A (de)
ZA (1) ZA908914B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824662A (en) 1996-09-27 1998-10-20 Guilford Pharmaceuticals Inc. Treatment of global and focal ischemia using naaladase inhibitors

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6017903A (en) 1996-09-27 2000-01-25 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors
JP2002514184A (ja) 1996-09-27 2002-05-14 ギルフォード ファーマスーティカルズ インコーポレイテッド Ｎａａｌａｄアーゼ組成物ならびに動物におけるグルタメート異常を治療する方法および神経活性をもたらす方法
DE19706903A1 (de) 1997-02-21 1998-08-27 Bayer Ag Verwendung von bekannten Agonisten des zentralen Cannabinoid-Rezeptors CB 1
AU743788B2 (en) * 1997-05-07 2002-02-07 Unimed Pharmaceuticals, Inc. Method of improving disturbed behavior and elevating mood in humans
ATE367809T1 (de) 1998-04-21 2007-08-15 Us Health Cannabinoiden als antioxidantien und neuroschützende mittel
ZA200802767B (en) 2005-09-29 2009-09-30 Amr Technology Inc Process for production of delta-9-tetrahydrocannabinol
DE102015112092B4 (de) 2015-07-24 2022-03-10 Beko Technologies Gmbh Öl/Wasser-Trennvorrichtung mit Druckluftbeaufschlagung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL48824A (en) * 1976-01-12 1980-05-30 Yissum Res Dev Co Pharmaceutical compositions containing (3s,js) tetrahydrocanabinol derivatives and some novel compounds of this type
US4133819A (en) * 1977-06-17 1979-01-09 Pfizer Inc. Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents
US4209520A (en) * 1977-06-17 1980-06-24 Pfizer Inc. Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents
IL80411A (en) * 1986-10-24 1991-08-16 Raphael Mechoulam Preparation of dibenzopyranol derivatives and pharmaceutical compositions containing them

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824662A (en) 1996-09-27 1998-10-20 Guilford Pharmaceuticals Inc. Treatment of global and focal ischemia using naaladase inhibitors
US5985855A (en) 1996-09-27 1999-11-16 Guilford Pharmaceuticals Inc. Treatment of global and focal ischemia using NAALADase inhibitors

Also Published As

Publication number Publication date
CA2029419A1 (en) 1991-05-08
EP0427518B1 (de) 1995-03-15
IL92238A0 (de) 1990-07-26
EP0427518A1 (de) 1991-05-15
AU631262B2 (en) 1992-11-19
ES2071786T3 (es) 1995-07-01
KR950005914B1 (ko) 1995-06-07
CA2029419C (en) 2004-05-25
DE69017839T2 (de) 1995-08-31
ZA908914B (en) 1991-09-25
JPH0768235B2 (ja) 1995-07-26
ATE119898T1 (de) 1995-04-15
DE69017839D1 (de) 1995-04-20
KR910009687A (ko) 1991-06-28
JPH03209377A (ja) 1991-09-12
AU6583490A (en) 1991-05-30
DK0427518T3 (da) 1995-07-24

Similar Documents

Publication Publication Date Title
US5284867A (en) NMDA-blocking pharmaceutical compositions
EP1299374B1 (de) Neue nicht psychotropische cannabinoide
AU766988B2 (en) Cannabinoids as antioxidants and neuroprotectants
US5932610A (en) Tumor necrosis factor α (TNF-α) inhibiting pharmaceuticals
US6117844A (en) Method and composition for antiviral therapy
US20030153541A1 (en) Novel anticholesterol compositions and method for using same
AU675092B2 (en) Methods of combating (pneumocystis carinii) pneumonia and compounds useful therefor
FR2466248A1 (fr) Derives d'agents anti-inflammatoires non steroides, procede de preparation et compositions pharmaceutiques les contenant
EP1315506B1 (de) Phospholipidderivate von valproinsäure und ihre kombinationen
JP2003533478A (ja) （３ｒ，４ｒ）−δ８−テトラヒドロカンナビノール−１１−酸に基づく細胞増殖の低減方法
CA2029419C (en) Nmda-blocking pharmaceutical compositions
EP1542664A2 (de) Verfahren und zusammensetzungen zur behandlung von makula- und retina-erkrankungen
US20070099988A1 (en) Anti-emetic uses of (3r, 4r)-delta8-tetrahydrocannabinol-11-oic acids
WO2011153353A1 (en) Tocopherol derivatives and methods of use
WO2006043260A2 (en) Orally effective cannabinoid analogs
US7235584B2 (en) Non-psychotropic cannabinoids
AU2003302578A1 (en) High enantiomeric purity dexanabinol for pharmaceutical compositions
JPS58500995A (ja) 緑内障治療用組成物
NL2022615B1 (en) Pharmaceutical composition comprising tetrahydrocannabivarin for the prevention and treatment of overweight
JPS6245525A (ja) 脂質低下剤
EP0935964A1 (de) Pharmazeutische Zusammensetzungen, die NSAIDs und Piperine enthalten
WO2007047010A2 (en) Anti-emetic uses of cannabinoid analogs
EP1785417A2 (de) Neuartige nicht-psychotrope Cannabinoide

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees